Research News 2
-
Tracking COVID-19’s Impact and Vaccine Uptake in the Asia-Pacific Region
TREAT Asia program launches new website with up-to-date data across graphs, tables, and maps charting the impact of COVID-19 in the region.
-
Researchers Report New Case of Spontaneous HIV Cure
A woman in Argentina has become only the second documented person whose own immune system appears to have cured her of HIV.
-
Keeping Dormant HIV Dormant
Researchers aim to find out if safe and effective drugs can be developed to permanently suppress the HIV reservoir.
-
Why Do Some Elite Controllers Stop Controlling HIV?
A small minority of people living with HIV can suppress their viral load to levels at which the risk of HIV transmission and disease development are very low—all in the absence of antiretroviral therapy.
-
Another HIV Vaccine Failure – What HIV and COVID Can Teach Each Other
At the end of the roughly four-year study, there were no significant differences in HIV acquisition between those who received the vaccine and those who got placebo.
-
A Promising, “Unusual” Approach to Targeting HIV Spike Protein
es of monoclonal antibodies were generated from rabbits immunized with a chemically stabilized form of the gp120/gp41 trimer.
-
Predicting Post-Treatment Control Before It Happens
Dr. Mohamed Abdel-MohsenThere is a pressing need for identification of blood tests that could help predict the likelihood of HIV remission after stopping antiretroviral therapy (ART) in the setting of HIV cure trials.
-
Mimicking CD4: A Bait and Switch Approach to Immunotherapy
This month we focus on another form of immunotherapy, also with the potential to facilitate eradication of HIV reservoirs as part of an HIV cure strategy.
-
CAR Cells, Revved Up
hen sought to determine if those cells could be enhanced with improvements on three fronts: 1) an increased ability to differentiate into mature, HIV-fighting cells; 2) enhanced resistance to infection and destruction by HIV; and 3) with improved anti-HIV capabilities.
-
Risks and Potential Benefits of Participating in Cure Research
Perceptions of cure trial participants concerning personal and community risks and benefits are relevant to such studies and have received little attention.
-
Immunotherapy Targeting HIV Reservoirs
Research Question CAR T cell therapy, which uses T cells that have been engineered to target specific proteins, has revolutionized the treatment of some blood cancers. Yet success in HIV has lagged and several challenges remain. For example, how can we ensure that the CAR T cells go to the areas where they are needed? […]
-
Prospects for an HIV/AIDS Cure: Opinions of People with HIV and Their Healthcare Providers
The authors concluded that educational strategies tailored specifically to each group are required to increase understanding of HIV cure research and the role of ATI.
-
Mining the Blood for Markers of the Reservoir
The authors concluded that “the development of these tools may represent simple biomarkers for the rapid evaluation of changes in viral replication outside of the blood and changes in the reservoir size.”
-
HIV Reservoirs in the Blood and Gut Respond Differently to Virus Activators
The authors conclude that “it will be critical to evaluate the efficacy of LRAs in both blood and tissues” in order to develop more effective therapeutics in HIV cure strategies.